nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—Benzphetamine—SLC18A2—Parkinson's disease	0.0457	0.269	CrCbGaD
Oxaprozin—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—Parkinson's disease	0.0359	0.0432	CbGpPWpGaD
Oxaprozin—PTGS1—Eicosanoid Synthesis—PLA2G6—Parkinson's disease	0.0305	0.0368	CbGpPWpGaD
Oxaprozin—PTGS2—Eicosanoid Synthesis—PLA2G6—Parkinson's disease	0.0242	0.0292	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—Parkinson's disease	0.0239	0.0287	CbGpPWpGaD
Oxaprozin—Bifonazole—CYP2E1—Parkinson's disease	0.0238	0.14	CrCbGaD
Oxaprozin—CYP2C9—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.022	0.0265	CbGpPWpGaD
Oxaprozin—Modafinil—SLC6A3—Parkinson's disease	0.0219	0.129	CrCbGaD
Oxaprozin—CYP2C9—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.0201	0.0243	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—HMOX1—Parkinson's disease	0.0201	0.0242	CbGpPWpGaD
Oxaprozin—Benzphetamine—SLC6A3—Parkinson's disease	0.019	0.112	CrCbGaD
Oxaprozin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MCCC1—Parkinson's disease	0.0183	0.022	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—AIF1—Parkinson's disease	0.0168	0.0203	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—HMOX1—Parkinson's disease	0.016	0.0192	CbGpPWpGaD
Oxaprozin—Propafenone—CYP2D6—Parkinson's disease	0.0137	0.0807	CrCbGaD
Oxaprozin—CYP2C9—Xenobiotics—CYP2D6—Parkinson's disease	0.0137	0.0164	CbGpPWpGaD
Oxaprozin—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.0132	0.0159	CbGpPWpGaD
Oxaprozin—CYP2C9—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.0131	0.0158	CbGpPWpGaD
Oxaprozin—CYP2C9—Xenobiotics—CYP2E1—Parkinson's disease	0.0125	0.015	CbGpPWpGaD
Oxaprozin—CYP2C9—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.012	0.0145	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0118	0.0142	CbGpPWpGaD
Oxaprozin—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.0105	0.0126	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Parkinson's disease	0.00987	0.0119	CbGpPWpGaD
Oxaprozin—Propafenone—ABCB1—Parkinson's disease	0.00979	0.0577	CrCbGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00958	0.0115	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00874	0.0105	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00874	0.0105	CbGpPWpGaD
Oxaprozin—PTGS1—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00828	0.00998	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—GDNF—Parkinson's disease	0.00823	0.00991	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAG—Parkinson's disease	0.00823	0.00991	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00817	0.00984	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.008	0.00963	CbGpPWpGaD
Oxaprozin—Diphenhydramine—CYP2D6—Parkinson's disease	0.00799	0.047	CrCbGaD
Oxaprozin—PTGS2—Spinal Cord Injury—VIM—Parkinson's disease	0.00773	0.00932	CbGpPWpGaD
Oxaprozin—Methadone—CYP2D6—Parkinson's disease	0.00771	0.0454	CrCbGaD
Oxaprozin—PTGS2—Spinal Cord Injury—PDYN—Parkinson's disease	0.00752	0.00906	CbGpPWpGaD
Oxaprozin—Carbamazepine—ABCB1—Parkinson's disease	0.00749	0.0441	CrCbGaD
Oxaprozin—Phenytoin—ABCB1—Parkinson's disease	0.00728	0.0429	CrCbGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—TNF—Parkinson's disease	0.00714	0.0086	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—GFAP—Parkinson's disease	0.00707	0.00852	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—GSTA4—Parkinson's disease	0.00701	0.00844	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00694	0.00836	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—PLA2G6—Parkinson's disease	0.00677	0.00816	CbGpPWpGaD
Oxaprozin—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00669	0.00806	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00658	0.00792	CbGpPWpGaD
Oxaprozin—PTGS2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00657	0.00792	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—HSPA8—Parkinson's disease	0.00645	0.00777	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Parkinson's disease	0.00638	0.00769	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00638	0.00768	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—MAOB—Parkinson's disease	0.00625	0.00753	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00618	0.00745	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00613	0.00739	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—IL6—Parkinson's disease	0.00576	0.00694	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00567	0.00683	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—TNF—Parkinson's disease	0.00567	0.00683	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00559	0.00674	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00552	0.00665	CbGpPWpGaD
Oxaprozin—Methadone—ABCB1—Parkinson's disease	0.0055	0.0324	CrCbGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00527	0.00635	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00519	0.00625	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00512	0.00616	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00499	0.00601	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00487	0.00587	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00486	0.00586	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP2D6—Parkinson's disease	0.00464	0.00559	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.0046	0.00554	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—IL6—Parkinson's disease	0.00457	0.00551	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—GSTM1—Parkinson's disease	0.00453	0.00546	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00438	0.00528	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00435	0.00525	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP2E1—Parkinson's disease	0.00425	0.00512	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.0042	0.00506	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00418	0.00504	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00414	0.00499	CbGpPWpGaD
Oxaprozin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Parkinson's disease	0.0039	0.00469	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00388	0.00468	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—INS—Parkinson's disease	0.00387	0.00466	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00386	0.00465	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.00369	0.00444	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00363	0.00438	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—BDNF—Parkinson's disease	0.00362	0.00436	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Parkinson's disease	0.00359	0.00433	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—COMT—Parkinson's disease	0.00352	0.00424	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—GSTP1—Parkinson's disease	0.0035	0.00422	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—MAOA—Parkinson's disease	0.00349	0.00421	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00346	0.00417	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.00328	0.00396	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—GSTM1—Parkinson's disease	0.00322	0.00388	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00308	0.00371	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—INS—Parkinson's disease	0.00307	0.0037	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00289	0.00348	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00279	0.00336	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Parkinson's disease	0.00261	0.00315	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.0025	0.00301	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00246	0.00297	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.00244	0.00294	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00242	0.00292	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00242	0.00292	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00241	0.0029	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—VPS35—Parkinson's disease	0.00233	0.0028	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00229	0.00276	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MCCC1—Parkinson's disease	0.00228	0.00275	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ND3—Parkinson's disease	0.00228	0.00275	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.00223	0.00269	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.0022	0.00265	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00218	0.00263	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MCCC1—Parkinson's disease	0.00216	0.00261	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—OMD—Parkinson's disease	0.00215	0.00258	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TALDO1—Parkinson's disease	0.00215	0.00258	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00209	0.00252	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00204	0.00246	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NDUFB11—Parkinson's disease	0.00203	0.00245	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—OMD—Parkinson's disease	0.00203	0.00245	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TALDO1—Parkinson's disease	0.00203	0.00245	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GCH1—Parkinson's disease	0.00194	0.00234	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00192	0.00232	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.00185	0.00223	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.00184	0.00222	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.00184	0.00221	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.00182	0.0022	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00182	0.00219	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL1B—Parkinson's disease	0.00181	0.00218	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MCCC1—Parkinson's disease	0.00181	0.00218	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ND3—Parkinson's disease	0.00181	0.00218	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CASP3—Parkinson's disease	0.00181	0.00218	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00175	0.00211	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GBA—Parkinson's disease	0.00173	0.00208	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—DBH—Parkinson's disease	0.00173	0.00208	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—FBP1—Parkinson's disease	0.00173	0.00208	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TALDO1—Parkinson's disease	0.0017	0.00205	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—OMD—Parkinson's disease	0.0017	0.00205	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.00169	0.00204	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00169	0.00204	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00167	0.00201	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00166	0.002	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TAF1—Parkinson's disease	0.00164	0.00198	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FBP1—Parkinson's disease	0.00164	0.00198	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NDUFB11—Parkinson's disease	0.00161	0.00195	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GCH1—Parkinson's disease	0.00154	0.00186	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00139	0.00167	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—FBP1—Parkinson's disease	0.00137	0.00165	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—DBH—Parkinson's disease	0.00137	0.00165	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GBA—Parkinson's disease	0.00137	0.00165	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00134	0.00162	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	0.00131	0.00158	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL6—Parkinson's disease	0.00131	0.00158	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SNCA—Parkinson's disease	0.00131	0.00158	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00127	0.00153	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—DDC—Parkinson's disease	0.00127	0.00153	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.00123	0.00148	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ND3—Parkinson's disease	0.0012	0.00145	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.0012	0.00145	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.0012	0.00144	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00118	0.00143	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.00113	0.00136	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—OMD—Parkinson's disease	0.00113	0.00136	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.00113	0.00136	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.00108	0.0013	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.00107	0.00129	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MAOB—Parkinson's disease	0.00107	0.00129	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	0.00106	0.00128	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.00102	0.00123	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00102	0.00123	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—DDC—Parkinson's disease	0.00101	0.00121	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL23A—Parkinson's disease	0.000993	0.0012	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL14—Parkinson's disease	0.000993	0.0012	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA4—Parkinson's disease	0.000952	0.00115	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00094	0.00113	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF20—Parkinson's disease	0.000926	0.00112	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPS8—Parkinson's disease	0.000926	0.00112	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00092	0.00111	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000909	0.0011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000909	0.0011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000909	0.0011	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000894	0.00108	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLA2G6—Parkinson's disease	0.000857	0.00103	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MAOB—Parkinson's disease	0.000848	0.00102	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000807	0.000973	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.000794	0.000957	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CTGF—Parkinson's disease	0.00078	0.000939	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000726	0.000875	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000718	0.000865	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TH—Parkinson's disease	0.000708	0.000853	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ADRBK1—Parkinson's disease	0.000681	0.00082	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYCS—Parkinson's disease	0.00068	0.000819	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HSPA1A—Parkinson's disease	0.000676	0.000814	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000667	0.000804	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2D6—Parkinson's disease	0.00063	0.000759	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.00063	0.000759	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000622	0.00075	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CTGF—Parkinson's disease	0.000619	0.000745	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—COMT—Parkinson's disease	0.000602	0.000725	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—Parkinson's disease	0.000599	0.000722	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MAOA—Parkinson's disease	0.000598	0.00072	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HMOX1—Parkinson's disease	0.000591	0.000712	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2E1—Parkinson's disease	0.000577	0.000695	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NQO1—Parkinson's disease	0.00057	0.000687	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000567	0.000684	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCB1—Parkinson's disease	0.000567	0.000683	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TH—Parkinson's disease	0.000562	0.000677	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000562	0.000677	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—Parkinson's disease	0.00055	0.000663	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYCS—Parkinson's disease	0.00054	0.00065	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000535	0.000644	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPX1—Parkinson's disease	0.000527	0.000635	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—Parkinson's disease	0.000486	0.000586	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—COMT—Parkinson's disease	0.000478	0.000576	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—Parkinson's disease	0.000476	0.000573	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MAOA—Parkinson's disease	0.000474	0.000572	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HMOX1—Parkinson's disease	0.000469	0.000565	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—Parkinson's disease	0.000461	0.000556	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOE—Parkinson's disease	0.000453	0.000546	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCB1—Parkinson's disease	0.00045	0.000542	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—Parkinson's disease	0.000437	0.000526	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOE—Parkinson's disease	0.000429	0.000517	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPX1—Parkinson's disease	0.000418	0.000504	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000417	0.000503	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.00041	0.000494	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—INS—Parkinson's disease	0.000387	0.000466	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—Parkinson's disease	0.000386	0.000465	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000382	0.00046	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000378	0.000455	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TH—Parkinson's disease	0.000372	0.000448	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—INS—Parkinson's disease	0.000367	0.000442	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOE—Parkinson's disease	0.00036	0.000433	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.000357	0.00043	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—COMT—Parkinson's disease	0.000316	0.000381	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—Parkinson's disease	0.000315	0.000379	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MAOA—Parkinson's disease	0.000314	0.000378	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMOX1—Parkinson's disease	0.000311	0.000374	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—INS—Parkinson's disease	0.000307	0.00037	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCB1—Parkinson's disease	0.000298	0.000359	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—Parkinson's disease	0.000289	0.000349	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPX1—Parkinson's disease	0.000277	0.000334	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—Parkinson's disease	0.000256	0.000308	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOE—Parkinson's disease	0.000238	0.000287	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—INS—Parkinson's disease	0.000203	0.000245	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—Parkinson's disease	0.00016	0.000193	CbGpPWpGaD
